Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2026CureusOpen Access

Delayed Autoimmune Hemolytic Anemia After Remission in Non-Hodgkin Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

NANicholas AzingeTBTigabu BishawRVRaghav Veluri

Discussion

Loading...

Member takes

Overview

Case reports delayed autoimmune hemolytic anemia in a lymphoma survivor, indicating need for ongoing monitoring and care.

Key Points

  • Investigate the occurrence of delayed autoimmune hemolytic anemia in a patient with a history of non-Hodgkin lymphoma.
  • Detailed clinical evaluation of a 46-year-old male with NHL in remission.
  • Laboratory analysis including hemoglobin levels, LDH, and immunoglobulin profiling.
  • Imaging studies to assess for residual lymphomatous tissue and abnormalities.
  • Therapeutic interventions with corticosteroids, IVIG, and rituximab.
  • Confirmed warm autoimmune hemolytic anemia with low hemoglobin and elevated LDH levels.
  • Documented mesenteric calcifications suggesting ongoing lymphoproliferative activity.
  • Successful stabilization of hemolysis after treatment escalation to rituximab.
  • Highlighted the importance of careful monitoring of blood counts and lab values.

Cite This Study

Azinge et al. (2026) studied this question.

synapsesocial.com/papers/69ccb76c16edfba7beb8963ehttps://doi.org/10.7759/cureus.106120
View Full Paper
Ask AI
Bookmark
Share